Gatekeeping procedures in dose-response clinical trials based on the Dunnett test

被引:22
|
作者
Dmitrienko, Alex
Offen, Walt
Wang, Ouhong
Xia, Dan
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Wyeth Global Biostat, Collegeville, PA USA
关键词
multiple testing; gatekeeping tests;
D O I
10.1002/pst.190
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper discusses multiple testing procedures in dose-response clinical trials with primary and secondary endpoints. A general gatekeeping framework for constructing multiple tests is proposed, which extends the Dunnett test [Journal of the American Statistical Association 1955; 50: 1096-1121] and Bonferroni-based gatekeeping tests developed by Dmitrienko et al. [Statistics in Medicine 2003; 22:2387-2400]. The proposed procedure accounts for the hierarchical structure Of the testing problem; for example, it restricts testing of secondary endpoints to the doses for which the primary endpoint is significant. The multiple testing approach is illustrated using a dose-response clinical trial in patients with diabetes. Monte-Carlo simulations. demonstrate that the proposed procedure provides a power advantage over the Bonferroni gatekeeping procedure. The power gain generally increases with increasing correlation among the endpoints, especially when all primary dose-control comparisons are significant. Copyright (C) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 50 条
  • [1] A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints
    Xu, Haiyan
    Nuamah, Isaac
    Liu, Jingyi
    Lim, Pilar
    Sampson, Allan
    PHARMACEUTICAL STATISTICS, 2009, 8 (04) : 301 - 316
  • [2] ON CLOSED TEST PROCEDURES FOR DOSE-RESPONSE ANALYSIS
    ROM, DM
    COSTELLO, RJ
    CONNELL, LT
    STATISTICS IN MEDICINE, 1994, 13 (15) : 1583 - 1596
  • [3] Mixture-based gatekeeping procedures in adaptive clinical trials
    Kordzakhia, George
    Dmitrienko, Alex
    Ishida, Eiji
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (01) : 129 - 145
  • [4] A note on tree gatekeeping procedures in clinical trials
    Dmitrienko, Alex
    Tamhane, Ajit C.
    Liu, Lingyun
    Wiens, Brian L.
    STATISTICS IN MEDICINE, 2008, 27 (17) : 3446 - 3451
  • [5] Fallback tests in dose-response clinical trials
    Dmitrienko, Alex
    Wiens, Brian
    Westfall, Peter
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2006, 16 (05) : 745 - 755
  • [6] THE DOSE-RESPONSE RELATIONSHIP AND CLINICAL-TRIALS
    MAXWELL, C
    DOSE-RESPONSE RELATIONSHIPS IN CLINICAL PHARMACOLOGY, 1989, 808 : 131 - 143
  • [7] Multistage and Mixture Parallel Gatekeeping Procedures in Clinical Trials
    Dmitrienko, Alex
    Kordzakhia, George
    Tamhane, Ajit C.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2011, 21 (04) : 726 - 747
  • [8] Dose-Response Determination in Multistage Endpoint Clinical Trials
    Chen, Fei
    Pinheiro, Jose
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014, 48 (01) : 56 - 61
  • [9] Dose-Response Determination in Multistage Endpoint Clinical Trials
    Fei Chen
    José Pinheiro
    Therapeutic Innovation & Regulatory Science, 2014, 48 : 56 - 61
  • [10] Rehabilitation and functional neuroimaging dose-response trajectories for clinical trials
    Dobkin, BH
    NEUROREHABILITATION AND NEURAL REPAIR, 2005, 19 (04) : 276 - 282